ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Approach to the management of patients with newly diagnosed anaplastic thyroid cancer

Approach to the management of patients with newly diagnosed anaplastic thyroid cancer
This algorithm is intended for use in newly diagnosed, untreated patients with anaplastic thyroid cancer who do not require emergency intervention to secure the airway or avert impending neurovascular compromise. For use in conjunction with UpToDate content on anaplastic thyroid cancer.
AJCC: American Joint Committee on Cancer; PET: positron emission tomography; CT: computed tomography; MRI: magnetic resonance imaging.
* Neck ultrasound, PET/CT (neck to pelvis), brain MRI or CT. All anaplastic cancers are considered stage IV cancers. Best supportive care/hospice is an alternative to mutational testing if aggressive care is not desired.
¶ Specific inhibitors of oncogenic ALK, NTRK, or RET fusion mutations can be considered for unresectable stage IVB disease or stage IVC disease, preferably within the context of a clinical trial.
Δ Surgery followed by chemoradiation is an alternative in patients with resectable IVB disease.
Consider surgery for resectable cervical disease if low volume M1, followed by chemoradiation.
§ If unfavorable response to dabrafenib plus trametinib, options include chemoradiation, clinical trials, and best supportive care.
Reference:
  1. ​AJCC Cancer Staging Manual, 8th ed, Amin MB, Gress DM, (Author), Vega LM, et al (Eds), American College of Surgeons 2018.
Graphic 130965 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟